Low-dose olanzapine after highly emetogenic chemotherapy can be the new standard of care for solid tumours

Cancer care in Needle Hospital, Hargeisa, Somaliland

Relapsed refractory multiple myeloma

The evolving paradigm in management of Multiple Myeloma

Special issue on real world breast cancer data

Chairperson: Evidence Communication

Patient benefit vs industry benefit finding a balance

Haemato-oncological Cancers

Hope vs Hype of evidence interpretation

Shared decision making (Patient-oncologist)

Panelist - Patient Advocacy Panel discussion

Real world evidence research – asking the right question